Novo Nordisk , the Danish drugmaker, was cut to hold from buy at Jefferies, which cited concern ahead of a US decision on Victoza.
118826
Novo Nordisk cut to hold at Jefferies
85933
Credit Suisse cut price for Nufarm
69835
Barrick upgraded to 'buy' from 'hold'
152068
GateHouse media suspends dividend
112289
Drug stocks retract;
155737
Citigroup says US government delaying sale of stake
87879
News Corp. withdraws bid to purchase Newsday
49396
AstraZeneca abandoning anti-ovarian cancer drug
25459
Jd Wetherspoon suspends dividend
66817
Vivendi cut to hold at Deutsche Bank
115137
Metals producers may delay takeover bids
19259
SIRIUS XM Radio downgraded from buy to hold
159318
Amgen forced to suspend trial of promising cancer drug
156016
Lonmin rejects takeover bid from Xstrata
79889
Merck buys drug rival Schering-Plough
41015
Nordion agrees to sell Belgian subsidiary to Best Medical for undisclosed amount
144222
Jaques decides to delay return